RxDoctor Payments Data

Gabriel Mansouraty, MD

Gastroenterology · Greensboro, NCNPI 1689960155

Payments from drug & device makers

$1,561in general payments, 2019–2025

Across 68 payments — averaging $22.95 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boston Scientific$191
  • AbbVie$186
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$174
  • Johnson & Johnson$129
  • Steris Corporation$120
  • Medtronic$103
  • plus $657 from 18 others

What the payments were for

  • Food & beverage$1,53999%
  • Education$221%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,561 in reported general payments places this provider in the 40th percentile of 610 gastroenterology providers in North Carolina.

See all gastroenterology providers in North Carolina

Medicare billing

Part B allowed, 2024
$78,105
Medicare patients
237
Services billed
809

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
LinzessLinaclotide46$27,299
Sod Sulf-Potass Sulf-Mag SulfSodium, Potassium,mag Sulfates148$10,040
TrulancePlecanatide12$6,851
EliquisApixaban11$6,369
Sucralfate132$6,199
Omeprazole223$4,649
Pantoprazole Sodium257$3,451
Esomeprazole Magnesium56$1,701
CholestyramineCholestyramine (With Sugar)14$1,335
Rabeprazole Sodium14$591
Peg 3350-ElectrolyteSodium Chloride/Nahco3/Kcl/Peg18$355
Diphenoxylate-AtropineDiphenoxylate Hcl/Atropine14$307
Famotidine23$306
Dicyclomine Hcl29$297
Ciprofloxacin Hcl52$188

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieLinzess$186$27,29946 claims
Salix Pharmaceuticals, A Division Of Bausch Health US, LLCTrulance$174$6,85112 claims
PfizerEliquis$23$6,36911 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 40th percentile of 610 gastroenterology providers in North Carolina.

Other gastroenterology in Greensboro

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →